Phospho-TDP43 (Ser409/410) Recombinant monoclonal antibody 80007-1-RR proteintech

$149.00
In stock
SKU
80007-1-RR
Catalog No.SizePrice (USD)
80007-1-RR-20UL20 μL$149.00
80007-1-RR-100UL100 μL$449.00
80007-1-RR-10X100UL1 mL (10 x 100 μL vials)$3,592.00
Catalog Number80007-1-RR
Synonymsp TDP43, p TDP43 (Ser409/410), p TDP43 Ser409/410, Phospho TDP43, Phospho TDP43 (Ser409/410)
HostRabbit
Reactivityhuman, mouse and More (1)
Reactivityhuman, mouse, zebrafish
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inHeLa cells, Calyculin A treated cells
Tested Applications — Positive IHC detected infrontal cortex of FTLD-TDP type B case, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inCalyculin A treated HeLa cells
Recommended Dilutions — Western Blot (WB)WB : 1:5000-1:50000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:500-1:2000
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Positive WB detected inHeLa cells, Calyculin A treated cells
Positive IHC detected infrontal cortex of FTLD-TDP type B case, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inCalyculin A treated HeLa cells
Western Blot (WB)WB : 1:5000-1:50000
Immunohistochemistry (IHC)IHC : 1:500-1:2000
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Tested Reactivityhuman, mouse
Cited Reactivityhuman, mouse, zebrafish
ClassRecombinant
TypeAntibody
ImmunogenPeptide Predict reactive species
Full NameTAR DNA binding protein
Calculated Molecular Weight43 kDa
Observed Molecular Weight45-50 kDa
GenBank Accession NumberNM_007375
Gene SymbolTDP-43
Gene ID (NCBI)23435
RRIDAB_2882937
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDQ13148
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for Phospho-TDP43 (Ser409/410) antibody 80007-1-RRDownload protocol
WB protocol for Phospho-TDP43 (Ser409/410) antibody 80007-1-RRDownload protocol
mouseIHC,IF Sci Transl Med A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury Authors - Xinyi Zhao View Article
zebrafishIHC,IF Mol Neurodegener Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits Authors - Yiying Hu View Article
mouse,humanWB,IHC,IF Mol Cell S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis. Authors - Wentao Xu View Article
humanWB Adv Sci (Weinh) Protein Disulfide Isomerase Disassembles TDP-43/G3BP1 Condensates and Antagonizes TDP-43 Pathological Aggregates. Authors - Jia-Qi Liu View Article
Rashmi (Verified Customer) (02-14-2025)used for Western blot, IHC, highly recommended Applications: Western Blot, Immunohistochemistry Primary Antibody Dilution: 1:1000 , 1:2000 Cell Tissue Type: HEK293T
Silvia (Verified Customer) (08-21-2020)Excellent phospho-specific TDP-43 antibody. Tested by IHC in ethanol and NBF fixed FTLD-TDP brains and ALS spinal cord. The antibody works well with citrate buffer and FA as antigen retrieval. The dilutions that worked better showing high specificity and low background ranged from 1,000-5,000.Works great also by western blot at dilutions 1:1,000-1:2,000. Applications: Western Blot, Immunohistochemistry, Immunofluorescence Primary Antibody Dilution: Wblot (1:1,000-2,000) IHC (1:1,500 - 1:5,000) Cell Tissue Type: human cortex and spinal cord Phospho-TDP43 (Ser409/410) Antibody Western Blot,Immunohistochemistry,Immunofluorescence validation (Wblot (1:1,000-2,000) IHC (1:1,500 - 1:5,000) dilution) in human cortex and spinal cord (Cat no:80007-1-RR)
Citations37
DilutionsWB : 1:5000-1:50000 IHC : 1:500-1:2000 IF/ICC : 1:200-1:800
IsotypeIgG
ClonalityRecombinant
Clone Number6M10
ConjugationUnconjugated

Transactivation response (TAR) DNA-binding protein of 43 kDa (also known as TARDBP or TDP-43) was first isolated as a transcriptional inactivator binding to the TAR DNA element of the HIV-1 virus. Neumann et al. (2006) found that a hyperphosphorylated, ubiquitinated, and cleaved form of TARDBP, known as pathologic TDP-43, is the major component of the tau-negative and ubiquitin-positive inclusions that characterize amyotrophic lateral sclerosis (ALS) and the most common pathological subtype of frontotemporal lobar degeneration (FTLD-U). Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659,19823856, 21666678, 22193176). 80007-1-RR is a recombinant rabbit monoclonal antibody recognizing TDP-43 only when phosphorylated at 409/410. Immunohistochemical analyses using this antibody only stain the insoluble inclusions in pathologic tissues without normal diffuse nuclear staining. Protocols Product Specific Protocols IF protocol for Phospho-TDP43 (Ser409/410) antibody 80007-1-RR Download protocol WB protocol for Phospho-TDP43 (Ser409/410) antibody 80007-1-RR Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. sPLA2-IIA modifies progranulin deficiency phenotypes in mouse models
    Journal: Mol Neurodegener | Authors: Cha Yang | Species: mouse | Application: WB
  2. Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits
    Journal: Mol Neurodegener | Authors: Yiying Hu | Species: zebrafish | Application: IHC,IF
  3. AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice
    Journal: Nat Commun | Authors: Defne A Amado
  4. S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis.
    Journal: Mol Cell | Authors: Wentao Xu | Species: mouse,human | Application: WB,IHC,IF
  5. A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury
    Journal: Sci Transl Med | Authors: Xinyi Zhao | Species: mouse | Application: IHC,IF
  6. Protein Disulfide Isomerase Disassembles TDP-43/G3BP1 Condensates and Antagonizes TDP-43 Pathological Aggregates.
    Journal: Adv Sci (Weinh) | Authors: Jia-Qi Liu | Species: human | Application: WB
  7. Protein Disulfide Isomerase Disassembles TDP-43/G3BP1 Condensates and Antagonizes TDP-43 Pathological Aggregates.
    Journal: Adv Sci (Weinh) | Authors: Jia-Qi Liu | Species: human | Application: WB
  8. A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in mice
    Journal: J Exp Med | Authors: David Brenner | Species: mouse | Application: IF
  9. Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease
    Journal: NPJ Parkinsons Dis | Authors: Cheryl E G Leyns | Species: human | Application: IHC
  10. Direct interaction between TDP-43 and Tau promotes their co-condensation, while suppressing Tau fibril formation and seeding.
    Journal: EMBO J | Authors: Francesca Simonetti | Species: human | Application: IF
  11. Arsenic exposure activates microglia, inducing neuroinflammation and promoting the occurrence and development of Alzheimer's disease-like neurodegeneration in mice
    Journal: Ecotoxicol Environ Saf | Authors: Bo Zhang | Species: mouse | Application: WB,IF
  12. TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis
    Journal: Acta Neuropathol Commun | Authors: Svetlana Djukic | Species: mouse | Application: IF
  13. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo
    Journal: Acta Neuropathol Commun | Authors: Henrick Riemenschneider | Species: mouse,human | Application: IHC,IF
  14. CK1δ/ε-mediated TDP-43 phosphorylation contributes to early motor neuron disease toxicity in amyotrophic lateral sclerosis
    Journal: Acta Neuropathol Commun | Authors: Vivian I Ko | Species: Mouse
  15. Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1C71G ALS mouse model
    Journal: Acta Neuropathol Commun | Authors: Zachary C E Hawley | Application: WB
  16. TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis
    Journal: Acta Neuropathol Commun | Authors: Svetlana Djukic | Species: mouse | Application: IF
  17. Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence
    Journal: Acta Neuropathol Commun | Authors: Joy Mitra | Species: mouse,human | Application: IHC
  18. Fructose-2,6-bisphosphate restores TDP-43 pathology-driven genome repair deficiency in motor neuron diseases.
    Journal: Commun Biol | Authors: Anirban Chakraborty | Species: human | Application: IHC,IF
  19. Fructose-2,6-bisphosphate restores TDP-43 pathology-driven genome repair deficiency in motor neuron diseases.
    Journal: Commun Biol | Authors: Anirban Chakraborty | Species: human | Application: IHC,IF
  20. A Panel of miRNA Biomarkers Common to Serum and Brain-Derived Extracellular Vesicles Identified in Mouse Model of Amyotrophic Lateral Sclerosis
    Journal: Mol Neurobiol | Authors: Natasha Vassileff | Species: mouse | Application: WB
  21. Perivascular phosphorylated TDP-43 inclusions are associated with Alzheimer's disease pathology and loss of CD146 and Aquaporin-4
    Journal: Brain Pathol | Authors: Jessica Santiago | Species: human | Application: IHC
  22. Detection of pTDP-43 via routine muscle biopsy: A promising diagnostic biomarker for amyotrophic lateral sclerosis
    Journal: Brain Pathol | Authors: Qi-Jie Zhang | Species: human | Application: IHC,IF
  23. Phosphorylated TAR DNA-Binding Protein-43: Aggregation and Antibody-Based Inhibition.
    Journal: Biochim Biophys Acta Mol Basis Dis | Authors: Josephine C Esposto | Application: WB
  24. Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols
    Journal: Sci Rep | Authors: Ruth Luthi-Carter | Species: human
  25. ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activation
    Journal: iScience | Authors: Baggio A Evangelista | Species: human | Application: WB,IF
  26. Regulation of TAR DNA binding protein 43 (TDP-43) homeostasis by cytosolic DNA accumulation
    Journal: J Biol Chem | Authors: Cha Yang | Species: mouse | Application: WB
  27. Cytoplasmic TDP-43 accumulation drives changes in C-bouton number and size in a mouse model of sporadic Amyotrophic Lateral Sclerosis
    Journal: Mol Cell Neurosci | Authors: Anna Normann Bak | Species: mouse | Application: IHC
  28. Locus coeruleus TDP-43 pathology in a community-based cohort: Clinical and pathological correlates.
    Journal: J Neuropathol Exp Neurol | Authors: Allison M. Neltner | Species: human | Application: IHC
  29. Aberrant NSUN1 activity connects m(5)C-RNA modification to TDP-43 neurotoxicity in ALS/FTD.
    Journal: Life Sci Alliance | Authors: Melissa Parra-Torres | Species: human | Application: WB,IHC
  30. Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
    Journal: Front Genet | Authors: Tanzeen Yusuff | Application: WB
  31. Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence
    Journal: Res Sq | Authors: Joy Mitra | Species: mouse | Application: IF
  32. Progranulin deficiency does not exacerbate TDP-43 pathology in TDP-43 transgenic mouse models
    Journal: NPJ Dement | Authors: Cha Yang
  33. TDP-43 pathology links innate and adaptive immunity in amyotrophic lateral sclerosis
    Journal: bioRxiv | Authors: Baggio A Evangelista | Species: human | Application: WB,IF
  34. Loss of FMRP in microglia promotes degeneration of parvalbumin neurons and audiogenic seizures via progranulin insufficiency.
    Journal: bioRxiv | Authors: Heng Li | Species: mouse | Application: IHC
  35. Fructose-2,6-bisphosphate restores TDP-43 pathology-driven genome repair deficiency in motor neuron diseases
    Journal: bioRxiv | Authors: Anirban Chakraborty | Species: mouse,human | Application: IF
  36. Elevated neuronal TAF15 expression induces oxidative stress and anxiety-related behavioral deficits.
    Journal: Cell Rep | Authors: Tuo Yi
  37. Elevated neuronal TAF15 expression induces oxidative stress and anxiety-related behavioral deficits.
    Journal: Cell Rep | Authors: Tuo Yi

Product Documents

Datasheet

Datasheet

Reviews

Write Your Own Review
You're reviewing:Phospho-TDP43 (Ser409/410) Recombinant monoclonal antibody 80007-1-RR proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.